Klomipramin Mylan (Clomipramine Hydrochloride)

Clomipramine, a tricyclic antidepressant, acts on serotonergic and noradrenergic pathways to treat several psychiatric conditions.

• Major depressive disorder: alleviates depressive symptoms and improves mood.
• Obsessive‑compulsive disorder: reduces compulsive thoughts and behaviors.
• Premenstrual dysphoric disorder: mitigates mood swings and irritability associated with the menstrual cycle.

• Clomipramine blocks the reuptake of the neurotransmitters serotonin and norepinephrine at neuronal synapses, leading to increased concentrations of these monoamines in the central nervous system. The elevated serotonergic and noradrenergic activity enhances mood regulation and reduces anxiety, which underlies its therapeutic effects in depression and obsessive‑compulsive disorder. Additionally, clomipramine exhibits mild antagonism at certain cholinergic and histamine receptors, contributing to its side‑effect profile.

Clomipramine may cause a range of adverse reactions, varying from common to serious.

Common Side Effects

• Dry mouth: reduced salivation leading to discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness: increased sedation or fatigue.
• Weight gain: increased appetite and body weight.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm that may require monitoring.
• Seizures: risk of convulsive episodes, especially at high doses.
• Severe hypotension: marked drop in blood pressure upon standing.

When prescribing clomipramine, clinicians should consider several safety precautions.

• Cardiac assessment: evaluate patient history of heart disease before initiating therapy.
• Drug interactions: review concomitant medications that affect serotonin levels to avoid serotonin syndrome.
• Age considerations: use caution in elderly patients due to increased risk of falls and anticholinergic effects.
• Suicide risk: monitor for worsening depression or emergence of suicidal thoughts, especially early in treatment.
• Pregnancy and lactation: assess risk versus benefit; clomipramine is generally not recommended without specialist advice.
• Store at ambient temperature: keep tablets in original packaging, protect from moisture and light.

Clomipramine can interact with several drugs, altering its efficacy or safety.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use may precipitate hypertensive crisis or serotonin syndrome.
• SSRIs or SNRIs: combined serotonergic agents increase risk of serotonin syndrome.
• TCAs with other anticholinergic drugs: may exacerbate anticholinergic toxicity.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, quinidine): can raise clomipramine plasma levels.
• Anticoagulants (e.g., warfarin): may enhance bleeding risk.
• Diuretics: may potentiate orthostatic hypotension.